Avinash Hosanagar, MD

  • 3Articles
  • 50KReads
  • 2021–2024Active
  • 12Collaborators
  • 11Citations

About

Avinash Hosanagar, MD is affiliated with Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan; Mental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, Michigan. Avinash Hosanagar has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2021 and 2024. Their work focuses on Psychedelics, Psychopharmacology, and Depression (MDD).

Publications

JCP
Clinical Outcomes of IV Ketamine for Depression
Original Research

Clinical Outcomes of IV Ketamine for Depression

January 8, 2024

Short-term clinical trials found intravenous (IV) ketamine to be effective in reducing depressive symptoms. This study assessed longer-term outcomes of IV ketamine for depression and explored treatment and patient...
, , , et al
JCP
ASCP Corner

Psychedelics and Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects

February 23, 2021

In addition to altering one’s perception of reality, psychedelics may be useful for treating certain psychiatric disorders. This brief review looks at the mechanisms behind their effects.
, ,
JCP
ASCP Corner

Psychedelics and Treatment of Psychiatric Disorders, Part 2: Review of the Evidence

February 23, 2021

Could psychedelics such as psilocybin and LSD be useful in treating MDD or other psychiatric disorders? This brief review looks at the evidence.
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe